Neuroblastoma
Showing 51 - 75 of 393
Pediatric Cancer, Hodgkin Disease, CD30-Positive DLBCL Trial in Milwaukee (anti-CD30 Bispecific Antibody-armed
Not yet recruiting
- Pediatric Cancer
- +11 more
- anti-CD30 Bispecific Antibody-armed anti-CD3-Activated Autologous T-cells (CD30 biAb-AATC)
-
Milwaukee, WisconsinChildren's Wisconsin
Sep 14, 2022
Ganglioneuroblastoma, Neuroblastoma Trial in Canada, Puerto Rico, United States (procedure, drug, biological, radiation)
Recruiting
- Ganglioneuroblastoma
- Neuroblastoma
- Autologous Hematopoietic Stem Cell Transplantation
- +18 more
-
Birmingham, Alabama
- +158 more
Sep 14, 2022
Neuroblastoma Trial in Worldwide (GM-CSF + Naxitamab)
Recruiting
- Neuroblastoma
- GM-CSF + Naxitamab
-
Gainesville, Florida
- +22 more
Aug 29, 2022
Neuroblastoma Trial in Worldwide (LY3295668 Erbumine, Topotecan, Cyclophosphamide)
Active, not recruiting
- Neuroblastoma
- LY3295668 Erbumine
- +2 more
-
San Francisco, California
- +21 more
Aug 17, 2022
Ganglioneuroblastoma, Nodular, Neuroblastoma Trial in Worldwide (Dinutuximab, Irinotecan, Isotretinoin)
Active, not recruiting
- Ganglioneuroblastoma, Nodular
- Neuroblastoma
- Dinutuximab
- +4 more
-
Mesa, Arizona
- +77 more
Aug 17, 2022
Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma Trial in Worldwide (Carboplatin,
Recruiting
- Ganglioneuroblastoma
- +3 more
- Carboplatin
- +6 more
-
Birmingham, Alabama
- +219 more
Aug 17, 2022
International PPB/DICER1 Registry
Recruiting
- Pleuropulmonary Blastoma
- +14 more
-
Minneapolis, MinnesotaChildren's Minnesota
Aug 16, 2022
Collecting and Storing Tissue From Young Patients With Cancer
Recruiting
- Acute Lymphoblastic Leukemia
- +13 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Birmingham, Alabama
- +68 more
Aug 4, 2022
Neuroblastoma, Osteosarcoma, Other Solid Tumor Cancers Trial in New York (Humanized 3F8 Bispecific Antibody, Blood draw)
Terminated
- Neuroblastoma
- +2 more
- Humanized 3F8 Bispecific Antibody
- Blood draw
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 11, 2022
Neuroblastoma, Childhood Metastatic Pheochromocytoma Trial in Philadelphia (131 I-Metaiodobenzylguanidine (131 I-MIBG), 131
Available
- Neuroblastoma
- Childhood Metastatic Pheochromocytoma
- 131 I-Metaiodobenzylguanidine (131 I-MIBG)
- 131 I-MIBG
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Jul 11, 2022
Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma Trial in Memphis (Fludarabine, Cyclophosphamide, MESNA)
Recruiting
- Pediatric Solid Tumor
- +15 more
- Fludarabine
- +3 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jun 30, 2022
Neuroblastoma Trial in New York (Hu3F8, GM-CSF, Isotretinoin)
Active, not recruiting
- Neuroblastoma
- Hu3F8
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 1, 2022
Neuroblastoma Trial in Guangzhou (Anti Thymocyte Globulin, Fludarabine, Cyclophosphamide injection)
Not yet recruiting
- Neuroblastoma
- Anti Thymocyte Globulin
- +10 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Jun 29, 2022
Neuroblastoma Trial in Los Angeles (Dinutuximab with Chemotherapy)
Not yet recruiting
- Neuroblastoma
- Dinutuximab with Chemotherapy
-
Los Angeles, CaliforniaChildrens Hospital Los Angeles
Jun 13, 2022
Neuroblastoma Biology Study
Recruiting
- Neuroblastoma
-
Los Angeles, California
- +13 more
May 18, 2022
Neuroblastoma Trial in New York (anti-GD2 murine IgG3 mAb 3F8)
Completed
- Neuroblastoma
- anti-GD2 murine IgG3 monoclonal antibody 3F8
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Apr 21, 2022
Familial Investigations of Childhood Cancer Predisposition
Recruiting
- Acute Leukemia
- +45 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
May 11, 2022
Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second
Recruiting
- Pediatric Solid Tumor
- +15 more
- second generation 4-1BBζ EGFR806-EGFRt
- second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
-
Seattle, WashingtonSeattle Children's Hospital
May 2, 2022